Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines

Thrombosis and Haemostasis

Volumn 93, Issue 4, 2005, Pages 761-769

  Bachmeier, Beatrice E ^a   Vené, Roberta ^b   Iancu, Cristina M ^a,c   Pfeffer, Ulrich ^b   Mayer, Barbara ^d   Noonan, Douglas ^b   Albini, Adriana ^b   Jochum, Marianne ^a   Nerlich, Andreas G ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

Breast cancer cell lines; Cell density; Gene silencing; Invasion; MMP regulation

Indexed keywords

COLLAGENASE 3; CRE RECOMBINASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN C FOS; PROTEIN C JUN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL DENSITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR SPHEROID; UPREGULATION;

EID: 16844375504     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-09-0601     Document Type: Article

References (57)

1. Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001; 11: 143-52.
2. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
3. Henriet P, Blavier L, Declerck YA. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS 1999; 107: 111-9.
4. Yoshizaki T, Maruyama Y, Sato H, et al. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 2001; 95: 44-50.
5. Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 2001; 151: 121-48.
6. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-92.
7. Bergman MR, Cheng S, Honbo N, et al. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 2003; 369: 485-96.
8. Takahra T, Smart DE, Oakley F, et al. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int J Biochem Cell Biol 2004; 36: 353-63.
9. Menashi S, Dehem M, Souliac I, et al. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int J Cancer 1998; 75: 259-65.
10. Igarashi T, Abe M, Oikawa M, et al. Retinoic acids repress the expression of ETS-1 in endothelial cells. Tohoku J Exp Med 2001; 194: 35-43.
11. Bachmeier BE, Nerlich AG, Boukamp P, et al. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1, -8, and -13 and of TIMP-1. Biol Chem 2000; 381: 509-16.
12. Bachmeier BE, Boukamp P, Lichtinghagen R, et al. Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 2000; 381: 497-507.
13. Meade-Tollin LC, Boukamp P, Fusenig NE, et al. Differential expression of matrix metalloproteinases inactivated c-ras-Ha-transfected immortalized human keratinocytes. Br J Cancer 1998; 77: 724-30.
14. Bachmeier BE, Nerlich AG, Lichtinghagen R, et al. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 2001; 21: 3821-8.
15. Benbow U, Schoenermark MP, Orndorff KA, et al. Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis 1999; 17: 231-8.
16. Balduyck M, Zerimech F, Gouyer V et al. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000; 18: 171-8.
17. Lebeau A, Muller-Aufdemkamp C, Allmacher C, et al. Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: Correlation with tumour growth. J Mol Histol 2004; 35: 443-55.
18. Bachmeier BE, Rohrbach H, DeWaal J, et al. Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas. Int J Oncol 2004; 00: 1-13.
19. Bachmeier BE, Albini A, Vene R, et al. Cell denisity-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. Exp Cell Res 2005; in press.
20. Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-21.
21. Zhang RD, Fidler IJ, Price JE. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991; 11: 204-15.
22. Soule HD, Vazguez J, Long A, et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409-16.
23. Kobayashi K, Rochat A, Barrandon Y. Segregation of keratinocyte colony-forming cells in the bulge of the rat vibrissa. Proc Natl Acad Sci USA 1993; 90: 7391-5.
24. Mayer B, Klement G, Kaneko M, et al. Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 2001; 121: 839-52.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
26. Nakada M, Nakamura H, Ikeda E, et al. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999; 154: 417-28.
27. Minami R, Tsunoda H, Iijima T, et al. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix. Mod Pathol 2003; 16: 1164-70.
28. Albini A. Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 1998; 4: 230-41.
29. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
30. Kleinman HK, McGarvey ML, Hassell JR, et al. Basement membrane complexes with biological activity. Biochemistry 1986; 25: 312-8.
31. Netzker R, Weigert C, Brand K. Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. Eur J Biochem 1997; 245: 174-81.
32. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997; 15: 519-26.
33. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001; 20: 438-52.
34. Kossakowska AE, Huchcroft SA, Urbanski SJ, et al. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996; 73: 1401-8.
35. Airola K, Karonen T, Vaalamo M, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999; 80: 733-43.
36. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996; 2: 461-2.
37. Tetu B, Brisson J, Lapointe H, et al. Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer. Hum Pathol 1998; 29: 979-85.
38. Nakopoulou L, Giannopoulou I, Gakiopoulou H, et al. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999; 30: 436-42.
39. Garbett EA, Reed MW, Brown NJ. Proteolysis in human breast and colorectal cancer. Br J Cancer 1999; 81: 287-93.
40. Benbow U, Rutter JL, Lowrey CH, et al. Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. Br J Cancer 1999; 79:221-8.
41. Azzam HS, Arand G, Lippman ME, et al. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 1993; 85: 1758-64.
42. Pardo A, Barrios R, Maldonado V, et al. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998; 153: 833-44.
43. Hasan S, Nakajima M. Retinoic acid synergizes with cyclic AMP to enhance MMP-2 basal promoter activity. Biochem Biophys Res Commun 1999; 258: 663-7.
44. Paal E, Thompson LD, Przygodzki RM, et al. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999; 12: 518-28.
45. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: E131-E136.
46. Smith LM, Wise SC, Hendricks DT, et al. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 1999; 18: 6063-70.
47. Angel P, Baumann I, Stein B, et al. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 1987; 7: 2256-66.
48. Kirstein M, Sanz L, Quinones S, et al. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J Biol Chem 1996; 271: 18231-6.
49. Rutter JL, Benbow U, Coon CI, et al. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 1997; 66: 322-36.
50. Xie B, Bucana CD, Fidler IJ. Density-dependent induction of 92-kd type IV collageriase activity in cultures of A431 human epidermoid carcinoma cells. Am J Pathol 1994; 144: 1058-67.
51. Behrens P, Rothe M, Wellmann A, et al. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 2001; 194: 43-50.
52. Yabe H, Fukuma M, Urano F, et al. Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo. Biochem Biophys Res Commun 2002; 293: 61-71.
53. Hotary KB, Allen ED, Brooks PC, et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33-45.
54. Hagedorn H, Schreiner M, Wiest I, et al. Defective basement membrane in laryngeal carcinomas with heterogeneous loss of distinct components. Hum Pathol 1998; 29: 447-54.
55. Klein CA. The systemic progression of human cancer: a focus on the individual disseminated cancer cell - The unit of selection. Adv Cancer Res 2003; 89: 35-67.
56. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 7737-42.
57. Bernards R, Weinberg RA. A progression puzzle. Nature 2002; 418: 823.